FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I wherein W is -CH2CH2-; X is N or CR6; R1 is selected from 5-6 membered heteroaryl, unsubstituted or substituted with 1 to 3 substituents, wherein said heteroaryl contains from 1 to 2 heteroatoms selected from a sulphur or nitrogen atom, and each of said substituents is independently selected from a halogen atom, straight or branched C1-C4 alkyl, straight or branched C1-C4 alkoxy, -NR10R11, -C(=O)R12, straight or branched C1-C4 alkanoyloxy, cyano, nitro, or two adjacent substituents together with the attached carbon atom form a 6-membered aromatic ring, a 5-membered saturated ring or a 5-membered heterocyclic ring containing 2 heteroatoms selected from an oxygen atom; R2 is selected from the following groups, unsubstituted or substituted with 1 to 3 substituents: straight or branched C1-C6 alkyl, C3-C7 cycloalkyl, a 6-membered heterocyclic group containing 1 heteroatom selected from a nitrogen atom, C6-aryl; wherein said substituent is selected from the group consisting of a halogen atom, straight or branched C1-C4 alkyl, straight or branched C1-C4 alkylsulphonyl group, tetrazolyl, cyano; each of R3, R4 and R5 is independently selected from the group consisting of H, straight or branched C1-C6 alkyl; values of other radicals are given in the patent claim. Invention also relates to a production method, a pharmaceutical composition and to the use of the compound. .
EFFECT: technical result: obtaining novel compounds of formula I, which have the properties of a CCR5 antagonist and can be used to treat human immunodeficiency virus (HIV) infection.
10 cl, 13 tbl, 181 ex
Title |
Year |
Author |
Number |
FLUORO-SUBSTITUTED CYCLIC AMINO COMPOUNDS AND METHODS FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF |
2013 |
- Lju Khun
- Chzhan Khajjan
- Chzhou Juj
- Fu Jan
- Tszjan Khualjan
- Tan Sitsan
- Chen Kajsjan
|
RU2605931C2 |
PYRROLO[2,1-f][1,2,4]TRIAZINE COMPOUND, METHOD FOR PRODUCTION AND USE THEREOF |
2013 |
- Yan Chunkhao
- Men Linkhua
- Chen Yankhun
- Van Syan
- Tan Tsun
- Li Tszyapen
- Din Tszyan
- Chen I
|
RU2589053C1 |
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION |
2018 |
|
RU2789449C2 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF |
2020 |
- Du, Vu
- Ven, Kun
- Fu, Ivej
- Lv, Khajbin
- Khe, Tszinyun
- Tsin, Dekun
- Li, Yuj
- Duan, Tszini
- Li, Yun
- Aj, Chaovu
- Tu, Chzhilin
- Chen, Yuanvej
- Li, Sinkhaj
- Li, Khajbo
|
RU2825000C2 |
NEW BIPHENYL COMPOUND OR ITS SALT |
2018 |
- Yamashita, Satoshi
- Ogawa, Takahiro
|
RU2765152C2 |
HETEROCYCLIC MUSCARINIC AGONISTS AND COMPOSITIONS, THEIR USING AND METHODS FOR TREATMENT |
2002 |
- Sk'Erbek Nil'S
- Kokh Kristian Norup
- Friberg Bo Lennart Mikaehl'
- Tol'F Bo-Ragnar
|
RU2292346C2 |
COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR |
2016 |
|
RU2718917C2 |
ISOQUINOLINONE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH POLY(ADP-ribose)POLYMERASE-1, CONTAINING THEM AS ACTIVE INGREDIENT |
2020 |
- Kim Eunhee
- Park Changmin
- Oh Sehwan
- Kim Younghoon
- Lee Juhee
- Seol Jaehee
- Shim Ahram
- Kim Younggwan
- Koo Tae-Sung
- Jang Ki-Hong
|
RU2815480C1 |
ANTITUMOR EFFECT ENHANCER USING NEW BIPHENYL COMPOUND |
2018 |
|
RU2765153C2 |
COMPOUNDS OF THIENYL[3, 2-d]PYRIMIDINE-4-ON, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION |
2012 |
- Lyu Khun
- Li Tszya
- Li Tszyan
- Li Tszingya
- Van Tszyan
- Su Minbo
- Lyan Tsze
- Tszyan Khualyan
- Chen Kajsyan
|
RU2624021C2 |